We are live on ! Find out more
PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
1-Year Est. Return 121.41%
This Fund
S&P 500
This Quarter Est. Return
+8.37%
1 Year Est. Return
+121.41%
3 Year Est. Return
+281.18%
5 Year Est. Return
+1,023.01%
10 Year Est. Return
–
AUM
$110M
AUM Growth
-$27M
Cap. Flow
-$12.6M
Cap. Flow %
-11.38%
Top 10 Hldgs %
100%
Holding
11
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CDLX icon
Cardlytics
CDLX
+$12.6M

Sector Composition

Rank Sector Weight
1 Healthcare 38.82%
2 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FATE icon
1
Fate Therapeutics
FATE
$307M
$25.3M 22.91%
1,139,783
– –
RNAC icon
2
Cartesian Therapeutics
RNAC
$243M
$6.68M 6.05%
92,449
– –
KALA icon
3
KALA BIO
KALA
$14M
$4.97M 4.5%
226
– –
XFOR icon
4
X4 Pharmaceuticals
XFOR
$397M
$3.12M 2.82%
10,383
– –
STIM icon
5
Neuronetics
STIM
$158M
$1.39M 1.25%
732,583
– –
GNCA
6
DELISTED
Genocea Biosciences, Inc.
GNCA
$423K 0.38%
246,078
– –
ATYR
7
aTyr Pharma
ATYR
$50.9M
$366K 0.33%
130,571
– –
PULM icon
8
Pulmatrix
PULM
$6.06M
$363K 0.33%
17,972
– –
DARE icon
9
Dare Bioscience
DARE
$19.6M
$277K 0.25%
27,187
– –
CDLX icon
10
Cardlytics
CDLX
$23.6M
– –
-20,000
Closed -$12.6M

Similar funds

IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM
AG
Ashmore Group London, United Kingdom $16.3M AUM 57.83% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
EIP
Edgbaston Investment Partners $20.3M AUM 35.98% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
OEP
Ocean Endowment Partners Chicago, Illinois $20.6M AUM 27.63% 1-Year Est. Return

Polaris Venture Management Co V's Q1 2020 Portfolio in Review

As of Q1 2020, Polaris Venture Management Co V held 11 positions worth $110M, down 20% from $137M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Polaris Venture Management Co V withdrew a net $12.6M in Q1 2020, closing 1 position. Its most notable exit was Cardlytics, an estimated $12.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 29% a quarter earlier, followed by Communication Services.

  • Polaris Venture Management Co V fully exited Cardlytics in Q1 2020, selling an estimated $12.6M.
  • Polaris Venture Management Co V's ten largest holdings make up 100% of its $110M portfolio in Q1 2020.
  • Polaris Venture Management Co V opened 0 new positions and closed 1 in Q1 2020.
  • Polaris Venture Management Co V's portfolio value fell 20% quarter-over-quarter to $110M.

Based on Polaris Venture Management Co V's 13F filing for Q1 2020, filed 14 May 2020.